Akero soars as drug shows it reverses scarring in liver disease patients
By Sriparna Roy (Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday, after its lead drug showed it can help patients with a type of liver disease to reverse scarring of the ...
Akero shares double after preliminary results from mid-stage trial for liver disease drug
(Reuters) -Akero Therapeutics shares gained 106% before the bell on Monday after its lead drug helped patients with a type of liver disease to reverse scarring of the organ without the worsening of ...